” You can anticipate even without additional doses from Johnson & & Johnson for us to be someplace in that community,” Slavitt stated at a coronavirus press instruction.
The United States still expects to meet its target for delivering COVID-19 vaccines despite Johnson & & Johnson dealing with production, a White Home senior aide said Monday.
Andy Slavitt, a senior consultant to President Bidens coronavirus action group, stated that the drugmaker is still on track to provide 24 million doses in April.
” You do the math. There is lots of supply to continue to immunize Americans at 3 million daily, and then some. Thats not to mention the fact that there are numerous doses that have currently been distributed into states.”
However the factory wasnt licensed to provide doses yet anyhow and is currently waiting on approval from US regulators.
The Centers for Disease Control and Prevention had actually said that deliveries of the vaccine were to plummet today by more than 80 percent, though the cause is unclear.
Some state officials blamed a contract plant in Baltimore, where a minimum of 15 million shots were polluted when employees reportedly blended up active ingredients with another shot.
Andy Slavitt, senior consultant to the White House COVID-19 Response Team, speaks during a White House instruction on the Biden administrations reaction to the COVID-19 pandemicAP
Adam Dentinger, a UPS shipment driver, rolls a freight cart of vaccine secondary kits at Louisville Metro Health and Wellness headquarters in LouisvilleGetty Images
” We are pleased by the reality that Johnson and Johnson in the meantime has actually taken control of the plant, has removed the confounding factor of another vaccine being produced there,” Slavitt said.
” And they stay positive that theyre going to have the ability to provide at or near 24 million this month and over or close to 100 million by May.”